Yu‐Wen E. Chang

790 total citations
20 papers, 664 citations indexed

About

Yu‐Wen E. Chang is a scholar working on Molecular Biology, Pharmacology and Oncology. According to data from OpenAlex, Yu‐Wen E. Chang has authored 20 papers receiving a total of 664 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Molecular Biology, 6 papers in Pharmacology and 6 papers in Oncology. Recurrent topics in Yu‐Wen E. Chang's work include Protein Kinase Regulation and GTPase Signaling (7 papers), Inflammatory mediators and NSAID effects (6 papers) and Estrogen and related hormone effects (4 papers). Yu‐Wen E. Chang is often cited by papers focused on Protein Kinase Regulation and GTPase Signaling (7 papers), Inflammatory mediators and NSAID effects (6 papers) and Estrogen and related hormone effects (4 papers). Yu‐Wen E. Chang collaborates with scholars based in United States, Taiwan and China. Yu‐Wen E. Chang's co-authors include Jolinda A. Traugh, Rolf Jakobi, Andrey Sorokin, Michael J. Dünn, Ann McGinty, Stephen G. Waxman, Joel A. Black, Lynda Tyrrell, Hye‐Sook Ahn and Jin‐Sung Choi and has published in prestigious journals such as Journal of Biological Chemistry, Journal of Neuroscience and Molecular and Cellular Biology.

In The Last Decade

Yu‐Wen E. Chang

20 papers receiving 657 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Yu‐Wen E. Chang United States 15 349 140 136 94 86 20 664
You Me Sung United States 12 514 1.5× 190 1.4× 183 1.3× 100 1.1× 91 1.1× 17 824
Shuiliang Yu United States 18 592 1.7× 88 0.6× 48 0.4× 85 0.9× 60 0.7× 25 796
E G Lapetina United States 14 535 1.5× 182 1.3× 77 0.6× 58 0.6× 74 0.9× 16 933
Akihisa Nagata Japan 10 332 1.0× 45 0.3× 103 0.8× 100 1.1× 43 0.5× 23 531
Hidekazu Yasui Japan 8 360 1.0× 65 0.5× 205 1.5× 50 0.5× 179 2.1× 10 694
Laurel M. Sam United States 13 493 1.4× 155 1.1× 70 0.5× 89 0.9× 143 1.7× 15 961
Tsukasa Sugo Japan 14 615 1.8× 151 1.1× 317 2.3× 45 0.5× 216 2.5× 20 1.3k
Mathieu Marella United States 18 794 2.3× 122 0.9× 57 0.4× 91 1.0× 147 1.7× 35 1.1k
Ichiro Isobe Japan 15 363 1.0× 184 1.3× 38 0.3× 107 1.1× 102 1.2× 32 761
Song Shi China 18 634 1.8× 207 1.5× 38 0.3× 174 1.9× 126 1.5× 28 1.0k

Countries citing papers authored by Yu‐Wen E. Chang

Since Specialization
Citations

This map shows the geographic impact of Yu‐Wen E. Chang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yu‐Wen E. Chang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yu‐Wen E. Chang more than expected).

Fields of papers citing papers by Yu‐Wen E. Chang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yu‐Wen E. Chang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yu‐Wen E. Chang. The network helps show where Yu‐Wen E. Chang may publish in the future.

Co-authorship network of co-authors of Yu‐Wen E. Chang

This figure shows the co-authorship network connecting the top 25 collaborators of Yu‐Wen E. Chang. A scholar is included among the top collaborators of Yu‐Wen E. Chang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yu‐Wen E. Chang. Yu‐Wen E. Chang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Niu, Rui, Lin Liu, Yu‐Wen E. Chang, et al.. (2021). Follistatin-like protein 1 functions as a potential target of gene therapy in proliferative diabetic retinopathy. Aging. 13(6). 8643–8664. 6 indexed citations
3.
Huang, Ming‐Hsi, Yu‐Wen E. Chang, I‐Hua Chen, et al.. (2016). Chimeric peptide containing both B and T cells epitope of tumor-associated antigen L6 enhances anti-tumor effects in HLA-A2 transgenic mice. Cancer Letters. 377(2). 126–133. 12 indexed citations
4.
Chang, Yu‐Wen E., et al.. (2015). Gemcitabine enhances antitumor efficacy of recombinant lipoimmunogen-based immunotherapy. OncoImmunology. 5(3). e1095433–e1095433. 17 indexed citations
6.
Stamboulian, Séverine, Jin‐Sung Choi, Hye‐Sook Ahn, et al.. (2010). ERK1/2 Mitogen-Activated Protein Kinase Phosphorylates Sodium Channel Nav1.7 and Alters Its Gating Properties. Journal of Neuroscience. 30(5). 1637–1647. 146 indexed citations
8.
9.
Chang, Yu‐Wen E., et al.. (2009). Targeting RhoA/Rho Kinase and p21-Activated Kinase Signaling to Prevent Cancer Development and Progression. Recent Patents on Anti-Cancer Drug Discovery. 4(2). 110–124. 25 indexed citations
10.
Chen, Hsin–Wei, Chih‐Hsiang Leng, Hsin‐Yu Liu, et al.. (2009). Identification of HLA-A11-restricted CTL epitopes derived from HPV type 18 using DNA immunization. Cancer Biology & Therapy. 8(21). 2025–2032. 14 indexed citations
11.
Chang, Yu‐Wen E., et al.. (2006). RhoA Mediates Cyclooxygenase-2 Signaling to Disrupt the Formation of Adherens Junctions and Increase Cell Motility. Cancer Research. 66(24). 11700–11708. 47 indexed citations
12.
Chang, Yu‐Wen E., et al.. (2005). Differential regulation of cyclooxygenase 2 expression by small GTPases Ras, Rac1, and RhoA. Journal of Cellular Biochemistry. 96(2). 314–329. 15 indexed citations
13.
Miller, Bradley, Yu‐Wen E. Chang, & Andrey Sorokin. (2003). Cyclooxygenase 2 inhibits SAPK activation in neuronal apoptosis. Biochemical and Biophysical Research Communications. 300(4). 884–888. 4 indexed citations
14.
McGinty, Ann, Yu‐Wen E. Chang, Andrey Sorokin, Dirk Bokemeyer, & Michael J. Dünn. (2000). Cyclooxygenase-2 Expression Inhibits Trophic Withdrawal Apoptosis in Nerve Growth Factor-differentiated PC12 Cells. Journal of Biological Chemistry. 275(16). 12095–12101. 76 indexed citations
15.
Chang, Yu‐Wen E., Rolf Jakobi, Ann McGinty, et al.. (2000). Cyclooxygenase 2 Promotes Cell Survival by Stimulation of Dynein Light Chain Expression and Inhibition of Neuronal Nitric Oxide Synthase Activity. Molecular and Cellular Biology. 20(22). 8571–8579. 66 indexed citations
16.
McGinty, Ann, Marco Foschi, Yu‐Wen E. Chang, et al.. (2000). Induction of prostaglandin endoperoxide synthase 2 by mitogen-activated protein kinase cascades. Biochemical Journal. 352(2). 419–424. 26 indexed citations
17.
Chang, Yu‐Wen E. & Jolinda A. Traugh. (1998). Insulin stimulation of phosphorylation of elongation factor 1 (eEF‐1) enhances elongation activity. European Journal of Biochemistry. 251(1-2). 201–207. 37 indexed citations
18.
Chang, Yu‐Wen E. & Jolinda A. Traugh. (1997). Phosphorylation of Elongation Factor 1 and Ribosomal Protein S6 by Multipotential S6 Kinase and Insulin Stimulation of Translational Elongation. Journal of Biological Chemistry. 272(45). 28252–28257. 45 indexed citations
19.
Chang, Yu‐Wen E., et al.. (1995). Phosphorylation of Elongation Factor 1 (EF‐1) by Protein Kinase C Stimulates GDP/GTP‐Exchange Activity. European Journal of Biochemistry. 234(2). 550–556. 42 indexed citations
20.
Venema, Richard C., et al.. (1994). GDP As a Regulator of Phosphorylation of Elongation Factor 1 by Casein Kinase II. Biochemistry. 33(28). 8515–8520. 14 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026